Literature DB >> 11762703

Effects of thyroid hormone on the renal dopaminergic system.

J A Del Compare1, J A Aguirre, F R Ibarra, M Barontini, I Armando.   

Abstract

This study determined the effects of thyroid hormone on the renal dopaminergic system. Surgical thyroidectomy (Tx) and treatment with 2-thiouracil (Thio) decreased renal cortex Na+/K+ ATPase activity and urinary volume. Tx also decreased urinary Na+ and urinary L-DOPA without changing urinary excretion of Dopamine (DA). Thio treatment decreased slightly urinary L-DOPA and Na+, but increased urinary excretion of DA. In both models of thyroid hormone deficiency, the ratio urinary DA/DOPA increased. Changes after Thio treatment were reversed after one month of drug withdrawal. Treatment with T3 via osmotic minipump increased Na+/K+ ATPase activity and urinary L-DOPA, did not change urinary DA, and increased the ratio DA/DOPA. To further analyze the effects of thyroid hormone deficiency, we administered selective DA1 (SCH-23390), DA2 (Sulpiride), and a non selective (Haloperidol) DA receptor antagonists to Thio treated and control animals. The DA1 antagonist decreased diuresis, natriuresis and urinary L-DOPA in control, but had no effect in Thio treated rats. Sulpiride had no effect in either group. The combination of SCH-23390 plus Sulpiride decreased urinary L-DOPA and urinary volume only in Thio treated animals. Haloperidol decreased urinary volume in Thio treated animals, but had no effect in controls. Our findings suggest that renal DA synthesis is to some extent dependent on thyroid hormone levels, and that the response of DA receptors is altered by thyroid hormone deficiency, indicating a role of this hormone in the regulation of the renal dopaminergic system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11762703     DOI: 10.1385/ENDO:15:3:297

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  29 in total

1.  Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.

Authors:  G Eisenhofer; D S Goldstein; R Stull; H R Keiser; T Sunderland; D L Murphy; I J Kopin
Journal:  Clin Chem       Date:  1986-11       Impact factor: 8.327

2.  Neonatal hypothyroidism induces striatal dopaminergic dysfunction.

Authors:  A Vaccari; Z L Rossetti; G de Montis; E Stefanini; E Martino; G L Gessa
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

Review 3.  Thyroid hormone and the kidney.

Authors:  A I Katz; D S Emmanouel; M D Lindheimer
Journal:  Nephron       Date:  1975       Impact factor: 2.847

4.  Urinary dopamine and sodium excretion in spontaneously hypertensive rats.

Authors:  C T Stier; H D Itskovitz; Y H Chen
Journal:  Clin Exp Hypertens       Date:  1993-01       Impact factor: 1.749

5.  Dopamine and the kidney: ten years on.

Authors:  M R Lee
Journal:  Clin Sci (Lond)       Date:  1993-04       Impact factor: 6.124

6.  Renal synthesis of dopamine in asymptomatic post-infarction left ventricular systolic dysfunction.

Authors:  A Ferreira; P Bettencourt; M Pestana; N Oliveira; P Serrão; M J Maciel; M Cerqueira-Gomes; P Soares-da-Silva
Journal:  Clin Sci (Lond)       Date:  2000-09       Impact factor: 6.124

7.  Energy expenditure associated with sodium/potassium transport and protein synthesis in skeletal muscle and isolated hepatocytes from hyperthyroid sheep.

Authors:  B W McBride; R J Early
Journal:  Br J Nutr       Date:  1989-11       Impact factor: 3.718

8.  Different mechanisms of renal Na-K-ATPase regulation by protein kinases in proximal and distal nephron.

Authors:  T Satoh; H T Cohen; A I Katz
Journal:  Am J Physiol       Date:  1993-09

9.  A decreased tubular uptake of dopa results in defective renal dopamine production in aged rats.

Authors:  I Armando; S Nowicki; J Aguirre; M Barontini
Journal:  Am J Physiol       Date:  1995-06

10.  Thyroid hormone coordinately regulates Na+-K+-ATPase alpha- and beta-subunit mRNA levels in kidney.

Authors:  A A McDonough; T A Brown; B Horowitz; R Chiu; J Schlotterbeck; J Bowen; C A Schmitt
Journal:  Am J Physiol       Date:  1988-02
View more
  3 in total

1.  Thyroid hormone treatments differentially affect the temperature kinetics properties of FoF1 ATPase and succinate oxidase as well as the lipid/phospholipid profiles of rat kidney mitochondria: a correlative study.

Authors:  Hiren R Modi; Samir P Patel; Surendra S Katyare; Minal Patel
Journal:  J Membr Biol       Date:  2007-06-14       Impact factor: 1.843

2.  Interactions between thyroid disorders and kidney disease.

Authors:  Gopal Basu; Anjali Mohapatra
Journal:  Indian J Endocrinol Metab       Date:  2012-03

3.  Unusual Presentation of Central Diabetes Insipidus in a Patient With Neurosarcoidosis.

Authors:  Vedha Sanghi; Aanchal Kapoor
Journal:  J Investig Med High Impact Case Rep       Date:  2016-09-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.